Terms ending in 2032
Every in-force patent on Translate Bio, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,143,758 | Liver Specific Delivery of Messenger RNA In force · Medium confidence | Translate Bio, Inc. | In force | Medium confidence | |
| US 11,224,642 | Mrna Therapy for Argininosuccinate Synthetase Deficiency In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 9,308,281 | Mrna Therapy for Fabry Disease In force · Low confidence | Translate Bio, Inc. | In force | Low confidence | |
| US 9,597,413 | Pulmonary Delivery of Mrna In force · Low confidence | Translate Bio, Inc. | In force | Low confidence | |
| US 10,238,754 | Lipid Nanoparticle Compositions and Methods for Mrna Delivery In force · Low confidence | Translate Bio, Inc. | In force | Low confidence | |
| US 10,350,303 | Lipid Nanoparticle Compositions and Methods for Mrna Delivery In force · Low confidence | Translate Bio, Inc. | In force | Low confidence | |
| US 10,413,618 | Lipid Nanoparticle Compositions and Methods for mRNA Delivery In force · Low confidence | Translate Bio, Inc. | In force | Low confidence | |
| US 10,507,183 | Cleavable Lipids In force · High confidence | Translate Bio, Inc. | In force | High confidence | |
| US 10,507,249 | Lipid Nanoparticle Compositions and Methods for Mrna Delivery In force · Low confidence | Translate Bio, Inc. | In force | Low confidence | |
| US 10,888,626 | Lipid Nanoparticle Compositions and Methods for Mrna Delivery In force · Low confidence | Translate Bio, Inc. | In force | Low confidence | |
| 20 more term ends in 2032 · Pro | |||||
10 of 30 patents shown. Soonest term end first, then patent number.
Pro members see all 30.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.